hVIVO expands biopharma capabilities with Cryostore acquisition
hVIVO plc has completed the acquisition of Cryostore Limited, a specialist provider of temperature-controlled storage solutions, in a deal valued at up to £3.2 million. ... Read More
hVIVO engages in major phase 2b influeness drug study as exclusive UK clinical site
hVIVO plc (AIM & Euronext: HVO), a rapidly expanding specialist contract research organisation (CRO) renowned for its expertise in human challenge clinical trials for infectious ... Read More